Saturday 17 October 2026
Export AMWL’s income statement to Excel — free account
American Well Corporation
AMWL Healthcare Health Information Services
American Well Corporation’s revenue for fiscal 2025 (year ended December 2025) was $249.3 million, down 1.98% from fiscal 2024. In the quarter to June 2026, revenue fell 26.6%, EPS grew 52.4% and free cash flow grew 266.4%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
11.68
0.70
−5.65%
Follow AMWL
| Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|---|---|
Piotroski F-Score |
— | — | — | — | 4 | 4 | 3 | 5 | 6 |
P/E ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Altman Z-Score |
— | — | — | 11.44 | 4.53 | 2.22 | (4.56) | (6.26) | (7.95) |
P/S ratio |
— | 0.00 | 0.00 | 10.23 | 6.07 | 2.79 | 1.59 | 0.43 | 0.32 |
Altman Z″-Score (non-manufacturers) |
— | — | (2.45) | 12.27 | 7.61 | 6.85 | (9.04) | (12.18) | (16.00) |
P/FCF ratio |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Beneish M-Score |
— | — | — | (2.42) | (2.03) | (2.67) | (7.12) | (3.25) | (3.29) |
P/Operating CF |
— | (38.99) | (38.99) | (102.27) | (34.16) | (21.51) | (9.91) | (8.09) | (4.54) |
P/B ratio |
— | 0.00 | 0.00 | 2.01 | 1.22 | 0.71 | 0.86 | 0.34 | 0.32 |
Price to Tangible BV |
— | 0.00 | 0.00 | 2.52 | 2.31 | 1.51 | 1.15 | 0.51 | 0.43 |
EV/Sales |
— | 0.00 | 0.00 | 5.98 | 3.12 | 0.85 | 0.15 | (0.47) | (0.42) |
EV/EBITDA |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.66 | 1.53 |
EV/Operating CF |
— | (6.08) | (6.08) | (13.04) | (5.57) | (1.22) | (0.27) | 0.94 | 1.57 |
EV/FCF |
— | (5.92) | (5.92) | (12.66) | (5.55) | (1.16) | (0.25) | 0.84 | 1.57 |
Quick Ratio |
— | 3.32 | 1.97 | 8.99 | 5.63 | 5.23 | 4.54 | 2.70 | 3.17 |
Current Ratio |
— | 3.39 | 2.10 | 9.20 | 5.84 | 5.49 | 4.79 | 2.85 | 3.37 |
Net Debt/EBITDA |
— | 5.37 | 2.09 | 4.85 | 4.65 | 2.18 | 1.68 | 1.26 | 2.69 |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Debt/Equity |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Asset Turnover |
— | 0.00 | 0.60 | 0.26 | 0.18 | 0.21 | 0.29 | 0.50 | 0.66 |
Operating CF/Net income |
— | 1.41 | 0.94 | 0.50 | 0.80 | 0.71 | 0.22 | 0.61 | 0.69 |
Capex/Depreciation |
— | (0.29) | (0.14) | (0.27) | (0.03) | (0.37) | (0.03) | (0.42) | 0.00 |
| — | 19.55% | 34.00% | (46.50%) | (14.07%) | (23.07%) | (86.34%) | (52.27%) | (33.93%) | |
| — | 0.00% | (34.88%) | (23.92%) | (12.49%) | (20.31%) | (74.72%) | (40.59%) | (25.19%) | |
ROIC |
— | 0.00% | 0.00% | (69.84%) | (21.76%) | (31.62%) | (400.00%) | (154.63%) | (100.51%) |
Return on Tangible Assets |
— | (24.73%) | (72.89%) | (22.53%) | (25.63%) | (52.66%) | (189.46%) | (100.99%) | (55.10%) |
Average Days of Receivables |
— | 99.29 | 80.25 | 67.41 | 74.18 | 76.86 | 76.29 | 103.15 | 72.75 |
Research and Development Expense of Revenue |
— | 31.83% | 36.24% | 34.42% | 42.17% | 49.96% | 40.85% | 33.84% | 29.22% |
Selling, General and Administrative Expense of Revenue |
— | 60.42% | 68.44% | 90.25% | 63.60% | 82.25% | 82.26% | 77.62% | 52.67% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.51 | 0.18 | 0.41 | 0.47 | 0.20 | 0.23 | 0.20 |
Share Based Compensation of Revenue |
— | 6.73% | 8.15% | 48.26% | 18.42% | 28.43% | 27.89% | 18.69% | 8.83% |
Graham Net Nets |
— | 0.20 | 0.20 | 0.39 | 0.42 | 0.64 | 0.83 | 1.81 | 2.17 |
Graham Number |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Earnings Yield |
— | (2.56%) | (2.56%) | (9.02%) | (11.42%) | (34.75%) | (165.52%) | (193.10%) | (121.18%) |
Free Cash Flow Yield |
— | (14.29%) | (14.29%) | (4.62%) | (9.26%) | (26.22%) | (39.69%) | (131.09%) | (83.73%) |
Revenue per Share |
— | 56.16 | 72.37 | 49.53 | 19.90 | 20.22 | 18.23 | 16.96 | 15.54 |
Operating CF per Share |
— | (36.47) | (39.81) | (22.71) | (11.14) | (14.03) | (10.44) | (8.49) | (4.11) |
Capex per Share |
— | (0.94) | (0.65) | (0.67) | (0.04) | (0.76) | (1.07) | (1.01) | 0.00 |
Free Cash Flow per Share |
— | (37.41) | (40.46) | (23.38) | (11.19) | (14.79) | (11.51) | (9.50) | (4.11) |
Cash per Share |
— | 128.62 | 86.35 | 210.55 | 58.76 | 39.28 | 26.18 | 15.22 | 11.36 |
Shareholders Equity per Share |
— | 0.00 | (136.54) | 251.65 | 99.25 | 79.06 | 33.79 | 21.08 | 15.44 |
Interest Debt per Share |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
— | 0.00 | (136.54) | 251.65 | 99.25 | 79.06 | 33.79 | 21.08 | 15.44 |
Free Cash Flow |
— | (75.92) | (83.23) | (115.78) | (142.10) | (202.77) | (163.59) | (142.56) | (65.97) |
Working Capital |
— | 210.00 | 116.95 | 992.31 | 685.67 | 512.56 | 355.79 | 205.73 | 173.47 |
Capital Expenditures |
— | (1.91) | (1.34) | (3.32) | (0.56) | (10.45) | (15.25) | (15.22) | (0.02) |
Net Current Asset Value |
— | 298.00 | (557.22) | 982.84 | 642.34 | 492.91 | 340.06 | 197.27 | 170.68 |
EV/EBIT |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.55 | 0.98 |
Capex to Sales |
— | 0.02 | 0.01 | 0.01 | 0.00 | 0.04 | 0.06 | 0.06 | 0.00 |
Price to Operating Income |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other line items | |||||||||
Depreciation/Fixed assets |
— | 2.17 | 3.58 | 3.24 | 8.41 | 28.13 | 822.87 | 95.45 | 167.12 |
Cash ROIC |
— | (29.09%) | 80.62% | (5.06%) | (7.08%) | (12.50%) | (19.20%) | (26.18%) | (15.34%) |
Accounts Receivable Turnover |
— | 3.56 | 4.67 | 6.29 | 5.23 | 5.05 | 4.60 | 4.04 | 4.10 |
Accounts Payable Turnover |
— | 10.66 | 15.23 | 25.49 | 16.54 | 16.55 | 27.15 | 31.46 | 34.95 |
Inventory Turnover |
— | 19.54 | 26.20 | 25.64 | 17.83 | 19.72 | 21.35 | 32.68 | 57.59 |
Average Days of Payables |
— | 24.91 | 29.68 | 13.50 | 29.88 | 16.46 | 10.81 | 11.78 | 5.17 |
Days of Inventory on Hand |
— | 18.68 | 14.17 | 21.25 | 18.51 | 19.88 | 14.78 | 6.71 | 3.72 |
Average Receivables |
— | 32.00 | 31.87 | 39.01 | 48.34 | 54.87 | 56.26 | 63.02 | 60.79 |
Average Payables |
— | 5.50 | 5.25 | 6.15 | 8.98 | 9.70 | 6.05 | 4.94 | 3.33 |
Average Inventory |
— | 3.00 | 3.05 | 6.12 | 8.33 | 8.13 | 7.69 | 4.76 | 2.02 |
Average Assets |
— | 0.00 | 249.94 | 938.26 | 1,411.24 | 1,331.70 | 903.63 | 512.84 | 379.88 |
Average Common Equity |
— | (269.50) | (256.43) | 482.67 | 1,253.54 | 1,172.36 | 782.02 | 398.22 | 282.02 |
Columns are period end dates